Does transrectal ultrasound guided eight-core prostate biopsy improve cancer detection rates in patients with prostate-specific antigen levels of 4.1-10 ng/mL?

International Journal of Urology

Volumn 11, Issue 6, 2004, Pages 386-391

  Yamamoto, Shinya ^a   Ito, Takaaki ^b   Aizawa, Taku ^c   Noda, Kenjiro ^d   Umezu, Kiyokazu ^d   Ohtsuru, Norihiko ^d   Hata, Kenichi ^d  

^a CHIBA CANCER CENTER   (Japan)

^b Kamata General Hospital   (Japan)

^c Nishi Tokyo Central General Hospital   (Japan)

^d TOKYO MEDICAL UNIVERSITY HACHIOJI MEDICAL CENTER   (Japan)

Author keywords

Eight core biopsy; Prostate specific antigen density; Prostate specific antigen levels of 4.1 10 ng mL

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EIGHT CORE PROSTATE BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SEXTANT BIOPSY; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 3042739517     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2004.00814.x     Document Type: Article

References (17)

1. Hodge KK, Mcneal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound-guided transrectal core biopsies of the prostate. J. Urol. 1989; 142: 71-5.
2. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J. Urol. 2000; 163: 163-7.
3. Ravery V, Goldblatt L, Royer B, Blanc E, Toublanc M, Boccon-Gimod L. Extensive biopsy protocol improves the detection rate of prostate cancer. J. Urol. 2000; 164: 393-6.
4. Durkan GC, Sheikh N, Johnson P, Hildreth AJ, Greene DR. Improving prostate cancer detection with an extended-core transrectal ultrasonography- guided prostate biopsy protocol. BJU Int. 2002; 89: 33-9.
5. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J. Urol. 1997; 157: 199-203.
6. Babaian RJ, Toi A, Kamoi K et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J. Urol. 2000; 163: 152-7.
7. Kojima M, Hayakawa T, Saito T, Mitsuya H, Hayase Y. Transperineal 12-core systematic biopsy in the detection of prostate cancer. Int. J. Urol. 2001; 8: 301-7.
8. Emiliozzi P, Longhi S, Scarpone P, Pansadoro A, DePaula F, Pansadoro V. The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen. J. Urol. 2001; 166: 845-50.
9. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: Impact on cancer detection. J. Urol. 2000; 164: 388-92.
10. Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J. Urol. 2000; 163: 158-62.
11. Chan TY, Chan DY, Stutzman KLRE, Epstein JI. Does increases in needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? J. Urol. 2001; 166: 2181-4.
12. Kanehara H, Ueda H, Katsuoka H. The efficacy of PSA density for the early detection of prostate cancer. Nihon Rinsho 1998; 56: 2012-20 [in Japanese].
13. Ohori M, Dunn JK, Scardino PT. Is prostate specific antigen density more useful than prostate specific antigen levels in the diagnosis of prostate cancer? Urology 1995; 46: 666-71.
14. Sasaki R, Habuchi T, Sato K. The clinical utility of measuring total PSA, PSA density, γ-seminoprotein and γ-seminoprotein/total PSA in prostate cancer prediction. Jpn. J. Clin. Oncol. 2000; 30: 337-42.
15. Ito K, Ohi M, Yamamoto T et al. The diagnostic accuracy of the age-adjusted and prostate volume-adjusted biopsy method in males with prostate specific antigen levels of 4.1-10.0 ng/mL. Cancer 2002; 95: 2112-19.
16. Djavan B, Waldert M, Zlotta A. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: Results of a prospective European Prostate Cancer Detection Study. J. Urol. 2001; 166: 856-60.
17. Rietbergen JB, Kruger AE, Kranse R et al. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology 1997; 49: 975-80.